Precision medicine is gaining real momentum across Asia Pacific as new tools and technologies enable treatments that target the root cause of disease. These therapies offer curative potential for conditions that previously had limited options.
L.E.K. Consulting's On the Cusp of a Cure series, supported by Johnson & Johnson, examines how ready the region is for this shift. Built on extensive evidence, it outlines the benefits of precision therapies, the barriers slowing adoption and the actions needed to strengthen system capability.
Watch the video to understand how precision therapies are shaping the next standard of care in Australia, China, Japan and Korea.
L.E.K. Consulting is a registered trademark of L.E.K. Consulting LLC. All other products and brands mentioned in this document are properties of their respective owners. © 2025 L.E.K. Consulting LLC
12192025001219